Minimally Invasive Gastrointestinal (GI) Surgical Systems are designed to aid surgeons in performing minimally invasive techniques, with greater accuracy and control. These systems have been proven to minimize the risk of adverse events as compared to traditional open surgery.
Minimally invasive gastrointestinal (GI) surgery uses special surgical techniques and instruments to perform procedures that were once done using open surgery. These techniques offer less trauma, less pain and shorter recovery times than traditional approaches.
Global minimally invasive gastrointestinal (GI) surgical systems market will reach $9,621.6 million by 2030, growing by 6.4% annually over 2020-2030 owing to the rising incidents of GI disorders, benefits offered by minimally invasive GI surgery, increasing R&D investments, and technological advancements in MIS and robotics-based surgeries.
Download Report Sample @ https://bit.ly/3trqf77
%20Surgical%20Systems.jpg)
Based on Product Type, the Minimally Invasive Gastrointestinal (GI) Surgical Systems is segmented into:
• Conventional Systems
o Endoscopes
o Videoscopes
o Endoscopic Ultrasound
o Therapeutic Energy Devices
o Other Components
• Robotic Systems
o Robot Machine
o Instruments and Accessories
o System Services
Based on Surgery Type, the Minimally Invasive Gastrointestinal (GI) Surgical Systems is segmented into:
• Hernia Repair
• Foregut Surgery
• Colon & Rectal Surgery
• Cholecystectomy
• Bariatric Surgery
• Appendectomy
• Adrenalectomy
Key Players Profiled in the Report:
B. Braun Melsungen AG
Boston Scientific Corporation
Conmed Corporation
Cook Medical, Inc.
Fujifilm Holdings Corporation
Intuitive Surgical, Inc.
Karl Storz SE & Co. KG
Medtronic plc
Olympus Corporation
Pentax Medical (Hoya Corporation)
Richard Wolf GmbH
Schölly Fiber Optic GmbH
Stryker Corporation
TransEnterix, Inc.
Xenocor, Inc.
